Medicines Co (MDCO) Tops Q4 EPS by 15c
Tweet Send to a Friend
Medicines Co (NASDAQ: MDCO) reported Q4 EPS of $0.26, $0.15 better than the analyst estimate of $0.11. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE